New study aims to catch rare cancers early in fanconi anemia patients
NCT ID NCT05687149
First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 1 time
Summary
This study follows people with Fanconi anemia, a rare inherited condition that raises the risk of certain cancers, especially squamous cell carcinoma. Researchers will screen 200 participants aged 12 and older every year for up to 10 years using exams, blood tests, and imaging to catch early signs of cancer. The goal is to understand how these cancers develop and improve early detection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FANCONI ANEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single drink reveal how alcohol triggers oral cancer?
- Gene therapy aims to fix bone marrow failure in fanconi anemia
- New transplant method aims to reduce complications in bone marrow failure patients
- New MRI method could spot oral cancer early in rare disease patients
- New hope for rare cancer: targeted drug afatinib tested in fanconi anemia patients
- New drug combo aims to make bone marrow transplants safer for kids